National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

broad-spectrum human papillomavirus vaccine V505
A non-infectious recombinant cancer vaccine prepared from the human papillomavirus (HPV) with potential immunoprophylactic activity. Vaccination with broad-spectrum human papillomavirus vaccine V505 may stimulate the host immune system to mount humoral and cytotoxic T lymphocyte (CTL) responses against HPV-infected cells. HPV infection, the cause of genital warts, is a risk factor for the development of cancers of the cervix, vagina, vulva, anus, and penis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:V505



Previous:Boswellia serrata extract, Bowman-Birk inhibitor concentrate, Brassica vegetable, brequinar, brivanib alaninate
Next:broccoli sprout extract, bromelain, bromocriptine mesylate, bromodeoxyuridine, bromovinyl-deoxyuridine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov